PL336786A1 - Application of a secretion vector in controlling fertility by means of an orally administered vaccine - Google Patents

Application of a secretion vector in controlling fertility by means of an orally administered vaccine

Info

Publication number
PL336786A1
PL336786A1 PL98336786A PL33678698A PL336786A1 PL 336786 A1 PL336786 A1 PL 336786A1 PL 98336786 A PL98336786 A PL 98336786A PL 33678698 A PL33678698 A PL 33678698A PL 336786 A1 PL336786 A1 PL 336786A1
Authority
PL
Poland
Prior art keywords
application
orally administered
secretion vector
administered vaccine
controlling fertility
Prior art date
Application number
PL98336786A
Inventor
Peter Donner
Werner Goebel
Andreas Demuth
Ivaylo Gentschev
Juergen Hess
Stefan Kaufmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PL336786A1 publication Critical patent/PL336786A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
PL98336786A 1997-05-07 1998-05-07 Application of a secretion vector in controlling fertility by means of an orally administered vaccine PL336786A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (en) 1997-05-07 1997-05-07 Process for the synthesis and secretion of proteins or protein fragments suitable for contraception by attenuated Salmonella or another Gram-negative attenuated vaccine strain to produce an oral vaccination
PCT/EP1998/002679 WO1998050067A2 (en) 1997-05-07 1998-05-07 Use or a secretion vector for fertility control by oral vaccination

Publications (1)

Publication Number Publication Date
PL336786A1 true PL336786A1 (en) 2000-07-17

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336786A PL336786A1 (en) 1997-05-07 1998-05-07 Application of a secretion vector in controlling fertility by means of an orally administered vaccine

Country Status (18)

Country Link
EP (1) EP1015023A1 (en)
JP (1) JP2002501507A (en)
KR (1) KR20010012257A (en)
CN (1) CN1255067A (en)
AU (1) AU7910798A (en)
BG (1) BG103850A (en)
BR (1) BR9809244A (en)
CA (1) CA2288602A1 (en)
DE (1) DE19720761A1 (en)
EE (1) EE9900516A (en)
HU (1) HUP0002752A2 (en)
IL (1) IL132521A0 (en)
IS (1) IS5199A (en)
NO (1) NO995429L (en)
PL (1) PL336786A1 (en)
SK (1) SK151799A3 (en)
TR (1) TR199902671T2 (en)
WO (1) WO1998050067A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (en) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Coated microorganism
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
WO2006121165A1 (en) * 2005-05-12 2006-11-16 Ajinomoto Co., Inc. Method for producing protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9094191A (en) * 1990-11-21 1992-06-25 Washington University Recombinant avirulent salmonella antifertility vaccines
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Also Published As

Publication number Publication date
EE9900516A (en) 2000-06-15
NO995429D0 (en) 1999-11-05
EP1015023A1 (en) 2000-07-05
WO1998050067A2 (en) 1998-11-12
IL132521A0 (en) 2001-03-19
IS5199A (en) 1999-09-28
SK151799A3 (en) 2000-06-12
CA2288602A1 (en) 1998-11-12
DE19720761A1 (en) 1998-11-12
NO995429L (en) 2000-01-07
CN1255067A (en) 2000-05-31
JP2002501507A (en) 2002-01-15
BR9809244A (en) 2000-06-27
BG103850A (en) 2000-05-31
KR20010012257A (en) 2001-02-15
AU7910798A (en) 1998-11-27
WO1998050067A9 (en) 1999-03-25
HUP0002752A2 (en) 2000-12-28
TR199902671T2 (en) 2000-09-21
WO1998050067A3 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
PL335974A1 (en) Method of orally administering proteins
GB9523244D0 (en) Therapeutic agents
GB9513117D0 (en) Therapeutic agents
SG113402A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
HUP9900252A3 (en) Hormonal pharmaceutical combined preparation for contraception and kit
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
AU1819897A (en) Medicinal prophylactic "trisan"
IL116590A0 (en) 3-phenylisoquinol-1(2h)-one derivatives their preparation and their therapeutic application
GB9519563D0 (en) Therapeutic agents
IL112745A0 (en) Formulations for orally administered pharmaceutical agents
PL336786A1 (en) Application of a secretion vector in controlling fertility by means of an orally administered vaccine
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AUPO503897A0 (en) Apparatus to manufacture "green" bricks
GB2331521B (en) Vaccine preparations
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents
CY2228B1 (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
EP1142589A4 (en) Medicinal preparations
LT97021A (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
IL130209A (en) Therapeutic application of a thienylcylohexylamine derivatives
IL115197A (en) Vaccine preparations for preventing vaginal infections
GB9507224D0 (en) Therapeutic agents
HK1025336A1 (en) Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
AU694084C (en) Apparatus to manufacture "green" bricks
AU721631C (en) Apparatus to manufacture "green" bricks
GB9604873D0 (en) Aid for cardiopulmonary resuscitation